NewMarket Corporation (NYSE: NEU) — Pricing Holds; Growth Must Earn Its Capital

Published: 2026-11-01 · Verdict: Hold · Entry price: $725 · Research confidence: High (84%)

Executive conclusion

Analyst Take

HOLD at $783.66, with moderate investment conviction. The 15.3% decline from the August report’s reference price materially improves the investment proposition. It does not establish that the shares are inexpensive. Current equity capitalization is approximately $7.21 billion and enterprise value approximately $7.96 billion, using September shares and filed net debt. That represents 11.6 times trailing operating EBITDA and 14.2 times operating profit. A central segment sensitivity produces approximately $808 per share, while an independently rebuilt five-year cash-allocation model produces an approximately 8.5% annual equity return. I would prefer an entry around $700–$725, where the modeled return and allowance for operating disappointment are more attractive. These are analyst judgments, not management guidance. S1 S2 [S7]

The central investment distinction is between an established franchise and an acquired growth platform. Afton has demonstrated that customers value qualified formulations, technical support and dependable supply. Petroleum Additives maintained approximately 20% operating margins despite declining shipments and renewed input and logistics pressure. Specialty Materials now contributes approximately $106 million of reconstructed trailing EBITDA. That is meaningful progress, and the earlier earnings checkpoint cannot reasonably remain entirely prospective. However, acquisition consideration, expansion spending, working capital and maintenance requirements determine the shareholder return. EBITDA alone cannot establish that the approximately $1 billion specialty capital commitment creates value. [S1] [S2] [S3]

The strongest new concern is physical demand. Third-quarter petroleum shipments declined 7.7%, following a 6.1% nine-month decline. Management attributes the latest quarter to broad market softness, especially lubricant additives; earlier elective reductions of low-margin business also affected the nine-month comparison. Those explanations should not be merged. Furthermore, Lubrizol reported higher first-half volumes, and Innospec’s Fuel Specialties volume increased 7% in Q2. Their portfolios and periods differ from Afton’s, so this does not prove lost share. It does weaken the comfortable assumption that every qualified supplier faces the same volume decline. [S2] [S23] [S47]

Earnings composition also warrants restraint. Nine-month operating profit increased 3.7%, versus 11.4% net-income growth. Lower taxes contributed substantially, while an $8.0 million decline in research and testing expense supported operating profit. Company-defined trailing EBITDA of $747.0 million retains $61.9 million of other income, predominantly pension-related. Operating-profit-based EBITDA is approximately $685.1 million using the company’s reconciliation D&A. Neither definition is inherently invalid, but they value different earnings streams. The operating valuation excludes other income, while the pension asset receives no separate value. [S1] [S2] [S3]

Cash provides the clearest adverse update. Nine-month operating cash flow declined to $354.7 million, and cash capital expenditures increased to $88.5 million. Analyst-defined free cash flow consequently fell 28.8% to $266.2 million. Inventory funding, longer transit times and higher input prices explain much of the deterioration according to management. That explanation is plausible and testable. It is not evidence that all the cash will reverse promptly. The balance sheet provides time to manage the disruption; it does not make inventory conversion or project economics optional. [S2]

The strongest counter-case remains substantial. Petroleum pricing could continue protecting attractive contribution while demand stabilizes. Both specialty projects could complete on schedule, qualify output and fill into sustained defense and space requirements. With modest leverage, limited dilution and a history of genuine share retirement, the resulting cash could compound per-share value without equity financing. The favorable scenario therefore requires operational execution, rather than financial engineering or a rescue. The recent specialty earnings improvement and maintained capacity timetable give this argument more substance than it had in August. [S2] [S3]

Evidence confidence is high for filed financial results, debt, acquisition accounting and dividends. It is lower for application-level market share, specialty organic growth, capacity commitments and acquisition-level returns. The two latest transcripts contain prepared remarks without public analyst Q&A. The next decision sequence is therefore practical: verify completion, observe qualified commercial shipments, assess petroleum volume against relevant markets and competitors, then test cash conversion. Stable qualified petroleum business, specialty organic growth and improving capital-inclusive cash returns would support a more favorable assessment. Continued shipment erosion, persistent inventory absorption or another acquisition before the present assets prove their returns would reduce conviction. [S8] [S9]

Changes since 2026-08-27

The valuation concern has eased, while operating uncertainty has increased. The reference price declined from $925.33 to $783.66. The prior selective accumulation ceiling of $775 did not trigger: the lowest subsequent intraday observation through October 30 was $781.75. That is a factual scorecard, not proof that either entry threshold was optimal. The current report also avoids carrying forward the prior valuation percentiles, which used different dates and measure definitions. [S7]

Specialty Materials has crossed $100 million of trailing reconstructed EBITDA. The prior report, however, required sustainable EBITDA and adequate returns after investment. A trailing accounting threshold is partial confirmation, not complete satisfaction of that test. Petroleum’s trailing margin remains above 20%, but surcharges remain in place, and qualified-volume retention is undisclosed. The prior surcharge-free durability test therefore remains open. [S1] [S2] [S3]

Several factual updates matter. The quarterly dividend increased to $3.25, or $13 annualized. Capital-spending guidance narrowed to $100–$120 million. Calca’s purchase-price allocation was finalized in Q3: identifiable intangibles decreased approximately $32 million, goodwill increased approximately $28 million, and deferred tax liabilities decreased approximately $4 million over the measurement period. The net-income effect was immaterial. This is an acquisition-accounting revision, not a new cash investment or evidence of improved acquisition economics. [S2] [S6]

Two analytical corrections improve comparability. Defined 2025 book ROIC is approximately 16.4%, with matched research capitalization reducing it to 14.0%–14.8%. The prior segment valuation did not explicitly capitalize corporate overhead; the present sensitivity does. Consequently, changes between the old and new segment values cannot be attributed entirely to price or operating developments. The core thesis survives: franchise durability is better established than growth quality, and the latest competitor evidence makes volume attribution more demanding. [S1] [S2] [S11] [S12] [S47]

Stock Price Action — Five-Year Event Map

On an unadjusted closing-price basis, NEU increased from $335.21 on November 1, 2021 to $783.66 on October 30, 2026, approximately 134%, excluding dividends. The lowest close was $281.43 on September 2, 2022; the highest was $961.92 on August 14, 2026. The latest close is 18.5% below that closing high. The trailing 52-week intraday range was approximately $580.03–$981.66, placing the current price about halfway through the range. Maximum closing-price drawdown in the five-year window was approximately 33.0%. [S7]

Price movements are measured observations; their operating explanations are interpretations. An earnings release can coincide with a large move without explaining every percentage point. The event map therefore establishes sensitivity to company information, not a causal decomposition of returns. The historical drivers are supported by the corresponding filings rather than retrospective price narratives. [S7] [S35] [S36] [S37]

The two sessions after the October release produced a cumulative 10.3% decline from October 28. Over August 26–October 30, NEU declined 15.3%, while IOSP increased approximately 4.4% and ECL approximately 4.3%, before dividends. This rejects a simple description of uniform selling across these selected companies. It does not establish abnormal returns against a properly estimated peer portfolio, nor prove an operating share shift. Their businesses, financial periods and starting valuations differ. [S7] [S27] [S29]

The practical implication is that low broad-market sensitivity offers limited protection from an earnings reset. A shareholder can own a sound business and still experience a large drawdown when expected growth, margins or reinvestment returns change. Conversely, a large decline is not independent evidence that expectations have become sufficiently conservative.

Verdict: The price reset is substantial and measurable. The history also demonstrates that company-specific earnings composition and valuation changes can overwhelm the stability implied by repeat consumption or a below-one market loading.

Business Overview

Two economic engines with different capital requirements

NewMarket operates principally through Petroleum Additives and Specialty Materials. Afton develops and supplies lubricant and fuel additives. Specialty Materials combines AMPAC’s perchlorate products with Calca’s high-purity hydrazine. Ethyl’s antiknock business and certain contracted manufacturing activities are reported in All Other. This last distinction corrects the earlier baseline’s overly broad placement of Ethyl inside Petroleum Additives. S1 [S2]

The business is understandable through qualified volume, price relative to inputs, technical spending, plant reliability and return on committed capital. Forecasting individual chemical molecules is unnecessary for the central investment judgment. It is necessary, however, to distinguish products whose customers purchase a validated formulation from products whose economics depend more heavily on delivered cost, program timing or capacity utilization.

Afton’s customers include integrated oil companies, independent lubricant manufacturers and blenders, refiners and fuel marketers. Lubricant customers combine additive packages with base oils to produce finished products. The package supplies properties such as wear protection, oxidation resistance, deposit control, friction performance and viscosity behavior. The commercial purpose is reliable equipment performance and support for a specification claim. Customers therefore buy chemistry together with formulation expertise, testing support and supply assurance. [S1]

A substitution decision illustrates the economics. A blender may obtain a cheaper package, but must determine whether the finished lubricant still supports the intended claims in its chosen base oils and viscosity grades. It must also consider consistency, technical response and consequences if the product fails. The relevant customer calculation compares total formulation cost and operating risk, not simply additive price per kilogram. This mechanism supports differentiation without implying that customers cannot qualify another incumbent.

Fuel additives serve a wider range of applications, including gasoline detergency, diesel performance, cetane improvement, lubricity, corrosion prevention and refinery needs. Competitive intensity differs across those uses. The four-platform description of lubricant packages should not be applied automatically to every fuel product. Afton’s reported segment economics combine these businesses and do not provide a complete fuel-only profit comparison. [S1]

Scale and revenue composition

Petroleum Additives generated approximately $2.534 billion of 2025 sales, including $2.156 billion of lubricant additives and $378 million of fuel additives. Specialty Materials generated approximately $182 million, including only the fourth quarter of Calca. Trailing September 2026 sales were approximately $2.521 billion for petroleum and $236 million for specialty. Petroleum consequently remains the dominant earnings and cash source even as specialty becomes more visible. [S1] [S2]

The weighting has an important implication. A small percentage change in the petroleum franchise can offset a large percentage increase in specialty. Investors should evaluate the second business’s absolute contribution rather than infer consolidated transformation from its growth rate alone. Conversely, specialty can become disproportionately valuable if qualified capacity produces high incremental cash returns, because its starting revenue base is small relative to the capital already committed.

AMPAC supplies ammonium perchlorate, an oxidizer used in solid rocket motors, and other perchlorates. Calca supplies high-purity hydrazine used in spacecraft propulsion. Their customers need specified particle characteristics or purity, controlled production processes, reliable delivery and approved supplier histories. A small material defect can jeopardize a costly program or mission, giving qualification and process consistency considerable economic importance. [S1]

These characteristics create a different revenue pattern. Deliveries depend on customer production schedules, defense appropriations, rocket-motor programs, satellite construction and shipment mix. A supplier can retain its qualification while a customer delays purchases. Qualification therefore supports relationship persistence more directly than quarterly revenue stability. The company explicitly expects substantial quarterly variation in specialty results. [S2] [S3]

Repeat consumption, geography and accounting recognition

Revenue is economically repeatable, but deliveries remain transactional and volume-sensitive. Petroleum contracts generally have one performance obligation satisfied when product is shipped, delivered or consumed, depending on terms. Specialty revenue is generally recognized when product ships from the plant. Customer prepayments totaled approximately $17 million in September. These facts do not establish a consolidated subscription-like revenue base or a disclosed take-or-pay floor. [S2]

Pricing can make sales look more stable than physical demand. Q3 petroleum sales were approximately unchanged despite a 7.7% shipment decline. This is favorable evidence of cost recovery, but stable revenue is insufficient to demonstrate stable customer activity. The appropriate operating bridge separates physical shipments, price, mix, currencies and acquisitions. Without that separation, nominal growth can conceal either deteriorating demand or improving economic selection.

Demand is international. Approximately 61% of 2025 consolidated sales were shipped outside the United States. Afton’s manufacturing and technical network supports multinational customers across major regions, while specialty sales are predominantly North American. Geographic breadth diversifies individual economies but introduces currency, freight, tariffs and coordination costs. A common global transport downturn can still affect several regions simultaneously. [S1]

Economic assets and security structure

Internally developed formulation knowledge, performance data, customer relationships and employee capability are largely expensed as created. Their economic value must be inferred from retained business, pricing and contribution after continued technical spending. The absence of a balance-sheet asset does not justify assigning an arbitrary technology valuation. Purchased specialty relationships and technology, by contrast, are already recognized substantially through acquisition accounting.

There are also specific balance-sheet qualifications. U.S. petroleum inventory was approximately $91 million below replacement cost at year-end 2025 under LIFO. NewMarket owns approximately 50 acres in Richmond, including corporate and research uses, but no independent surplus-property appraisal was established. The September prepaid pension asset of approximately $614 million can reduce future funding requirements, yet it is not unrestricted acquisition or distribution cash. None of these items receives an unsupported valuation uplift in the central analysis. [S1] [S2]

NEU is ordinary common stock of a Virginia corporation listed on the NYSE; it is not an ADR, MLP or partnership K-1 security. The investment is therefore an ordinary corporate equity claim whose value depends on operating cash generation, financial obligations and management’s allocation of retained resources. [S1]

Verdict: The operating model is comprehensible and differentiated. Its persistence comes from repeated customer activity and qualified relationships, while its risks come from physical demand, program timing, continuous technical investment and the price paid for acquired capabilities.

Industry Dynamics

Define the market before assigning the economics

NewMarket participates in several specialized markets rather than one uniform specialty-chemicals industry. Lubricant packages, fuel additives, perchlorates and high-purity hydrazine have different buyers, qualification systems, substitution risks and capital cycles. A single consolidated market-growth estimate would obscure these distinctions. Demand is international, but no reliable current consolidated market census was verified. The August report’s inflation-based extrapolation from a dated lubricant-additives estimate is not retained as a current market-size fact. [S1] [S21] [S22]

The lubricant chain starts with base oils and chemical intermediates, moves through functional components and formulated packages, then through finished-lubricant blending to equipment use. Commodity exposure is strongest in many upstream materials. The more attractive profit pool sits where a supplier combines chemistry, validation and technical support into a dependable performance system. Manufacturing scale supports that position, but does not independently reproduce a formulation library or an established customer approval.

NewMarket identifies Lubrizol, Infineum and Chevron Oronite as its principal lubricant-additive competitors. These suppliers, together with Afton, form the relevant global platform group. The filing also acknowledges other suppliers in particular product areas. Exact current shares, concentration ratios and comparable stand-alone profitability are unavailable. A stable roster supports the existence of entry barriers; it does not establish unchanged shares within that roster. [S1]

Fuel additives have more competitors. NewMarket names BASF, Innospec, Clariant and Dorf Ketal in relevant applications, alongside the larger lubricant platforms. Industry profitability must therefore be evaluated by application. Innospec Fuel Specialties’ approximately 19.5% Q2 operating margin supports the existence of a profitable technical niche, but does not define a universal fuel-additive margin or a direct target for Afton’s lubricant-heavy portfolio. [S1] [S23]

Barriers accumulate through qualification and technical scale

An entrant needs chemistry, reliable manufacturing, tests, formulation histories, customer support and a credible path to qualification. It must finance much of that system before substantial qualified revenue arrives. Incumbents can spread the fixed expense across established programs and apply prior learning to new customer requirements. This creates an economic barrier even where no individual patent prevents entry.

API’s current licensing framework makes part of the mechanism observable. Section 6.4.4 requires information on the final formulation, additive and base-oil content, engine tests, physical properties and traceability. Annex F restricts viscosity-grade read-across, including the detergent-inhibitor portion of the package. These rules increase the value of validated formulation breadth. They do not grant an additive supplier a legal monopoly or prevent a competing qualified package from winning business. S15

Emergency provisional licensing illustrates both sides. ILMA’s March announcement describes a mechanism for substitutions during disruption, with technical support, traceability and subsequent testing requirements. Approval rules remain economically relevant during supply stress, yet they also provide a route for customers to manage shortages. Regulation can strengthen the need for technical capability while helping buyers avoid absolute dependence on one existing formulation. [S41]

Industry margins are consistent with these barriers but also reveal their limits. Afton’s petroleum margin recovered from the low teens during the input shock to approximately 20%–22% subsequently. Qualified suppliers eventually recovered costs; they did not avoid the initial squeeze. The industry’s profitability depends on maintaining technical relevance and recovering costs without losing economically important business, rather than possessing automatic cost-plus contracts. [S1] [S10] [S11]

The supply side is active within the incumbent structure

Competition is becoming more capable regionally even though the principal global platforms remain established. Infineum inaugurated an Indian blending facility in March 2026, operated exclusively by LSR Specialty Oils. Local blending can shorten delivery times and improve responsiveness. It should not be equated with recreating every upstream component, research capability or global approval. The commercially relevant question is whether localization changes delivered cost and customer service enough to win programs. [S19]

Infineum’s Rianlon and Kangtai arrangements provide a more direct challenge to a static oligopoly interpretation. The January framework combines Infineum’s formulation expertise with regional component manufacturing and sourcing capability. The July announcement describes distribution of Kangtai components and industrial additives through Infineum’s Southern Asia channels. Kangtai’s disclosed capacity exceeds 150,000 tonnes, across a broader portfolio, with Malaysian expansion planned for 2028. [S17] [S18]

This is a credible route for lower-cost production to enter the commercial system without independently building a fifth complete global platform. It is not proof that Kangtai can immediately replace Afton’s qualified packages. The capacity figure covers several product types, and a component’s qualification differs from that of a finished package. Nevertheless, incumbent partnerships can transmit cost competition into established customer channels.

Foreign low-cost labor alone is an inadequate threat description. Labor savings do not automatically overcome testing, formulation, process-control and supply requirements. Lower-cost component production, customer-sponsored qualification and partnerships with established suppliers are more credible threats. Afton may also benefit from cheaper inputs. The distribution of those savings between suppliers and customers determines the eventual margin effect.

Mature petroleum demand and a different specialty expansion cycle

Petroleum-additive demand reflects equipment activity, lubricant consumption, drain intervals, specifications and powertrain mix. Better formulations can increase value per unit while extending fluid life and reducing physical consumption. Higher technical complexity and low volume growth can therefore coexist. This is a mature value-growth opportunity rather than an established high-volume expansion market.

The IEA reports electric cars at 25% of 2025 new-car sales and approximately 5% of the global car stock. Its definition includes battery-electric and plug-in hybrid cars; battery-electric vehicles represented approximately 65% of electric-car sales. The distinction matters because plug-in hybrids retain engines. The July update forecasts 29% electric penetration in 2026 new sales, but installed-fleet turnover remains slower. These figures support a long-duration engine-oil headwind, not an immediate equivalent reduction in Afton revenue. [S21] [S22]

Specialty Materials occupies a different supply cycle. NewMarket is adding qualified propulsion-chemical capacity into an opportunity management considers attractive. Qualification, hazardous-material requirements and approved processes limit immediate substitution. However, concentrated customers and governments can sponsor second sources to reduce dependence. Scarcity can protect an incumbent while encouraging future supply investment.

The company acknowledges perchlorate production in the United States and several foreign countries, while stating that competing producers generally lack qualification for most relevant U.S. defense and NASA programs. That is narrower than an absolute production monopoly. Hydrazine also faces architecture substitution: NASA describes demonstrated ASCENT-based propulsion and commercial development. Satellite growth cannot consequently be translated one-for-one into hydrazine demand. [S1] [S40]

Verdict: The relevant industries contain attractive, application-specific barriers. Petroleum combines mature demand with active incumbent and component competition; specialty combines scarce qualification with a new capacity cycle. Neither structure guarantees that incremental capital will earn an adequate return.

Competitive Position

The moat must appear in customer economics

Afton’s advantage combines qualification-based retention, accumulated formulation knowledge and technical scale. A customer with a working lubricant formulation must compare potential savings against testing, conversion, supply and performance risks. A supplier that reduces those burdens can retain business at an attractive contribution. The mechanism does not require an uncopyable molecule, but it does require continuing investment and dependable execution. [S1] [S15]

Switching costs include reformulation, testing, claims support, customer approval, production conversion and the risk of equipment or reputational damage. They vary by application. An OEM-specific driveline fluid is harder to replace than a simpler product for which the buyer already has multiple qualified alternatives. Public disclosure does not quantify retention, dual sourcing, average requalification expense or qualified wins and losses. The advantage is therefore supported more directly by mechanism and financial outcomes than by customer-cohort data.

Afton’s financial outcomes are meaningful. Petroleum operating margins were approximately 19.1% in 2023, 22.5% in 2024, 20.5% in 2025 and 20.7% over the latest trailing period. These results support differentiation beyond ordinary chemical conversion. The 2021–2022 squeeze is disconfirming evidence against unlimited pricing power: qualification did not eliminate pass-through lags, raw-material exposure or utilization sensitivity. [S1] [S2] [S10] [S11]

The latest quarter adds a useful stress test. Price and mix contributed approximately $52.3 million to petroleum sales, offsetting approximately $48.7 million of shipment pressure and an unfavorable currency effect. Segment operating profit was approximately flat. Customers accepted commercial measures sufficient to protect much of the profit despite disrupted costs. The company does not isolate a surcharge-free margin, so the result cannot establish that all current pricing survives normalization. [S2]

Financial resilience is not complete evidence of competitive success

Research and testing expense declined $8.0 million over nine months. Petroleum operating profit increased only approximately $2.1 million. Simple subtraction implies that, absent the lower research expense and without assuming other offsets, petroleum profit would have declined. This is not proof of underinvestment: testing schedules and project intensity vary. It does mean flat or slightly higher profit is an incomplete test of demand quality and operating improvement. [S2]

The most important contrary evidence comes from actual competitors. Lubrizol reported higher volumes and selling prices in the first half, with revenue up 7.0% and pretax earnings up 16.5%. Innospec Fuel Specialties reported 7% Q2 volume growth. These comparisons are imperfect: Lubrizol includes businesses beyond transportation additives, Innospec is more fuel-focused, and the latest Afton weakness is Q3. They nevertheless demonstrate that higher supplier volume was possible in adjacent and overlapping markets during 2026. [S23] [S47]

That evidence raises the burden on the pruning explanation. Elective account exits can improve returns if the surrendered contribution is genuinely low and assets or costs adjust accordingly. Persistent losses of attractive qualified programs would have a different meaning. The public record cannot fully separate those effects. A defensible thesis therefore requires a bridge from total shipment decline to retained qualified business and contribution, rather than treating every lost tonne as beneficial selection.

Shared advantages and the nature of rivalry

The comparison supports a durable place for Afton, rather than unique technological dominance. Customers can switch among established suppliers more readily than a new entrant can reproduce a global platform. New specifications can raise barriers to inexperienced suppliers while opening a fresh contest among incumbents. Qualification events can consequently strengthen the industry and redistribute business at the same time. [S1] [S17] [S19] [S23]

Brand matters as a technical reputation for performance, support and dependable supply. Finished-lubricant buyers generally choose the marketer’s brand rather than Afton’s name. Afton’s brand therefore operates within procurement and technical relationships. Its value should appear in access to programs, retained contribution and lower perceived failure risk. A performance incident or repeated delivery problems can weaken that asset even if the underlying chemistry remains capable.

Competition includes finished-formulation cost, performance, approved base-oil breadth, technical response, global availability and price. A package with a higher purchase price can still lower total customer cost by reducing testing or blending complexity. A rival can win by providing adequate performance with better regional delivery or lower total formulation cost. This is why comparing chemical prices alone understates the nature of rivalry.

Afton’s independence may appeal to lubricant marketers that compete with the parents of integrated suppliers. That is a plausible strategic benefit, not a quantified commercial premium. Independence also means the absence of a large captive downstream parent. The balance between neutrality and captive demand cannot be resolved from ownership structure alone.

Specialty qualification is narrower and more concentrated

AMPAC and Calca have process- and program-specific barriers. Approved particle characteristics, purity, audit histories and delivery reliability can be difficult to replace quickly. The consequences of failure strengthen the incumbent relationship. However, this dependence also creates an incentive for large customers to fund alternatives, especially after an outage or a period of constrained supply. [S1]

A supplier can remain competitive within hydrazine while losing demand if spacecraft adopt another propulsion architecture. NASA’s ASCENT material establishes a demonstrated alternative pathway, not a forecast of rapid displacement. The distinction is important: supplier qualification protects a position inside an architecture; it cannot guarantee that the architecture retains its share of future programs. [S40]

Verdict: Afton’s competitive advantage is credible, shared and costly to maintain. Specialty qualification can be stronger within individual programs, but site concentration and architecture risk increase the consequences of failure. Current evidence establishes attractive profitability more clearly than assured share retention or organic growth.

Growth History and Forward Opportunities

Separate price recovery, acquisition growth and organic expansion

The product outlook combines mature petroleum demand, specification-driven value and a specialty capacity ramp whose utilization remains unproven. Consolidated growth should be decomposed accordingly. Pricing that recovers inflation, acquired sales and new qualified volumes have different persistence, capital requirements and return implications. A single revenue or EPS growth rate cannot substitute for that decomposition. [S1] [S2] [S3]

Revenue increased from approximately $2.356 billion in 2021 to $2.725 billion in 2025, a 3.7% annual rate. Operating profit more than doubled. Much of the difference reflects recovery from the input-cost squeeze, rather than comparable expansion in physical demand. Petroleum sales declined from $2.690 billion in 2023 to $2.534 billion in 2025. Acquisitions supported the consolidated revenue base while the original segment contracted. [S1] [S10] [S11] [S12]

This history limits extrapolation. Another doubling of operating profit would require more than repeating the pass-through recovery from unusually depressed margins. The current petroleum margin already reflects much of that repair. Future earnings growth must come increasingly from retained contribution, specification value, productivity, specialty expansion or capital allocation, with each source evaluated on its own economics.

Petroleum opportunities use existing capabilities

Afton’s strongest organic opportunity is higher value per customer formulation. Evolving equipment requirements, lower viscosities, base-oil flexibility, durability and customer product simplification can increase the value of technical support. A supplier that helps a blender qualify a broader platform can reduce development work and participate in more applications. Existing laboratories, relationships and formulation histories can make incremental growth attractive relative to building a completely new manufacturing business. [S1] [S15]

The volume offset remains important. Better lubricants can extend drain intervals, and equipment designs can reduce fill requirements. Greater technical relevance need not increase tonnes. The economic objective should therefore be higher contribution and retained customer value, not an assumption that every specification upgrade expands treated volume. A favorable price-and-mix result accompanied by persistent qualified-program losses would be weaker than one supported by stable participation.

Hybrid and electric-vehicle fluids provide an adaptation route. Afton’s disclosed capabilities include friction control, materials compatibility, energy efficiency and electric-motor applications. These competencies are relevant to changing drivetrains. The company does not disclose sufficient revenue, content per vehicle, customer wins or contribution to establish that these products fully offset reduced conventional engine-oil and fuel demand. Their present value is strategic relevance with uncertain net replacement economics. [S1]

Regional growth is similarly conditional. Emerging vehicle fleets and industrial activity can support demand, while local technical service can improve share. However, recent regional revenue differences combine price, mix, currencies and shipments. Q3 Asia Pacific petroleum sales declined while other regions increased. Without a matched market denominator, neither regional revenue growth nor contraction proves a share change. The useful test is qualified participation and contribution after local support and logistics costs. [S2]

Specialty has demonstrated earnings progress

Specialty Materials’ nine-month sales increased to $187.3 million from approximately $134.0 million, while operating profit increased to $51.2 million from $39.7 million. Calca was absent from the prior-year period, and favorable shipment mix also contributed. These are real reported gains, but not a disclosed same-business organic growth rate. The October 2026 acquisition anniversary will progressively improve comparability, although shipment timing will remain important. [S2]

Quarterly variation is substantial. Specialty operating profit was approximately $22.3 million in Q2 and $16.4 million in Q3. Both exceeded their prior-year comparisons, but annualizing the best quarter would overstate the stability established by the record. Customer programs, product mix and shipment schedules can change the quarter without changing the long-term qualification position. Management explicitly warns that such variation will continue. [S2] [S4] [S8] [S9]

The reconstructed trailing result is approximately $58.5 million of operating profit plus $47.8 million of segment D&A, or $106.3 million of EBITDA. The D&A comes from disclosed segment tables; an unsupported estimate is unnecessary. This corrects the prior report’s statement that quarterly segment D&A was unavailable. The calculation confirms progress beyond $100 million while leaving cash conversion and full-capital returns unresolved. [S1] [S2]

Capacity completion is the first milestone

Management expects the ammonium-perchlorate and high-purity-hydrazine projects to complete by year-end 2026. The disclosed AMPAC project costs up to $100 million and adds approximately 50% capacity. The latest wording should be used rather than mechanically repeating an earlier greater-than-50% description. Construction completion, qualified output, customer acceptance and utilization are separate milestones. [S2] [S3]

The shareholder-value sequence extends further. Incremental sales must cover operating costs, working capital, maintenance, taxes and the resources already committed to acquire and expand the businesses. Mechanical completion can reduce construction risk while leaving demand and return risk largely intact. A lower capex forecast may reflect efficiency or expenditure timing; it cannot independently demonstrate a better project return.

An illustrative hurdle shows the remaining task. At a 23% tax assumption, an 8%–10% after-tax operating return on approximately $1 billion requires roughly $104–$130 million of annual operating profit. Current trailing specialty operating profit is about $58.5 million. This is not a measured segment ROIC because exact invested capital, tax attributes and maintenance requirements are insufficiently disclosed. It demonstrates why an EBITDA milestone and a satisfactory acquisition return are different tests.

Verdict: Petroleum offers specification, mix and productivity opportunities within mature demand. Specialty has become a meaningful earnings contributor and provides a credible expansion runway. The next evidence must establish qualified organic growth and cash returns after the capacity becomes available.

Financial Quality

Five-year operating and cash-flow reconstruction

Financial figures are U.S. dollars in millions unless stated otherwise. Free cash flow is analyst-defined operating cash flow less cash purchases of property, plant and equipment. Trailing figures equal FY2025 plus the first nine months of 2026 less the comparable 2025 period. These are reconstructed measures, not company guidance. Material amounts are reconciled to filings; Company Financials provides cross-checks and historical context. [S1] [S2] [S7] [S10] [S11] [S12]

The period contains a full cost-recovery and working-capital cycle. Inflation raised nominal sales in 2022 while cash conversion remained weak. Pricing subsequently caught up, input conditions improved and inventory released cash. By 2024, petroleum margins reached the best annual level in this comparison. FY2025 then combined petroleum normalization with a larger acquired asset base. These phases should not be collapsed into a smooth growth trend.

Earnings are above the input-cost trough and below the 2024 operating-profit peak. Petroleum is a qualified formulation business rather than a commodity whose price clears against a single global capacity curve. Nonetheless, the margin range is wide, and present surcharges complicate normalization. Specialty is earlier in its capacity cycle, but its acquisition price was paid before the eventual growth was demonstrated. [S1] [S2] [S10] [S11] [S12]

Segment economics and the latest earnings bridge

Specialty’s early comparison includes purchase accounting and changing ownership periods. AMPAC’s acquired inventory was marked to fair value, suppressing the accounting margin when sold. Later results include Calca. Neither sales nor profit therefore forms a clean organic series. Petroleum’s trailing profit is little changed from FY2025 despite much stronger reported net-income growth. [S1] [S2]

Nine-month consolidated operating profit increased $16.1 million to $449.8 million. Net income increased $38.5 million to $375.9 million. Research and testing expense declined from $100.6 million to $92.5 million, an $8.0 million benefit in the expense comparison. Lower research expense explains approximately half the operating-profit increase arithmetically, although this does not establish that spending was improperly reduced. Program timing, testing requirements and efficiency can all affect the expense.

Tax changes explain another substantial difference. Management attributes approximately $19 million of benefit to the lower effective rate. The nine-month rate was 20.6%, versus 24.6%; the Q3 rate was 17.9%, versus 26.1%. Prior-year estimate changes and lower foreign taxes were important. The valuation uses an explicit 23% normalization rather than treating the latest quarterly rate as permanent. A one-percentage-point rate change on roughly $524 million of operating profit after net interest changes normalized equity earnings by approximately $5.2 million. [S2]

The proxy uses approximately $571 million of 2025 bonus-plan operating profit, compared with $543.7 million GAAP. Its bridge excludes $10.8 million of bonus expense and $16.5 million of designated one-time items. Bonus expense is recurring compensation and is retained in the operating valuation. The designated one-time amount is a useful sensitivity, but the compensation measure should not be mistaken for a fully normalized earnings base. [S5]

Pension income and EBITDA scope

Nonservice pension and postretirement income is recorded outside operating profit. It was approximately $53 million in 2025 and $57 million over the latest trailing period. The pension asset has economic value, but its accounting income is not a manufacturing margin. Trailing other income totals $61.9 million, so describing all of it as pension income would also be inaccurate. [S1] [S2]

The company starts from net income and adds interest, taxes and its specified D&A. Other income consequently remains included. The separate approximately $1.4 million D&A difference between the earnings reconciliation and cash-flow statement is disclosed as a definition difference; no unsupported explanation is assigned. For comparisons, the numerator, denominator and treatment of financial assets must be consistent. [S2] [S3]

The pension credit should not simply be subtracted again from reported operating cash flow. The cash-flow reconciliation already adjusts net income for noncash pension effects within its reconciliation and separately reports contributions. Likewise, removing pension income from earnings and then adding a gross pension asset to valuation requires a separate, matched realization analysis. The central valuation avoids that unsupported addition.

Cash conversion has deteriorated

Nine-month CFO declined from $423.8 million to $354.7 million. Capex increased from $49.6 million to $88.5 million. FCF therefore declined from $374.2 million to $266.2 million, or 28.8%. Stand-alone Q3 CFO was approximately $68.6 million and FCF approximately $31.8 million, against $124.1 million of net income. This is a material divergence even though one quarter cannot establish a structural cash deficit. [S2] [S4]

Working capital absorbed $77.0 million, compared with a $4.5 million source previously. Inventory increased from $502.3 million at year-end to $576.6 million. Trade and other receivables also increased, while accounts payable provided a partial offset. Management identifies higher input prices, longer transit times and greater Q3 production as inventory drivers. These are management explanations to test against subsequent shipments, inventory turns and cash collections. [S2]

The distinction between trade working capital and accrued-liability financing matters. A cash improvement supported by genuine inventory conversion would be stronger than one financed mainly by delayed supplier payments or temporary accrual growth. Here, the latest cash deterioration is visible in the trade balance and expansion spending. It should not be explained away through a generic claim about accruals, nor treated as proof that inventory is obsolete.

Longer-period conversion remains supportive. FY2021–2025 CFO totaled approximately $1.94 billion and FCF approximately $1.62 billion, against $1.74 billion of net income. FCF was approximately 93% of cumulative earnings. The dispersion across years demonstrates why inventory-release cash cannot be capitalized as a perpetual run rate. The strong cumulative result supports earnings quality without excusing the latest deterioration. [S1] [S10] [S11] [S12]

Capital, ROIC and accounting asymmetry

The 2021 balance sheet additionally held approximately $375.9 million of marketable securities. Those investments must be subtracted alongside cash when constructing a consistent historical cash-netted capital measure. Acquisitions and pension-related equity movements also affect comparisons. Neither ending capital nor a standardized provider ratio is uniquely authoritative. [S1] [S2] [S7] [S11] [S13]

Defined book ROIC equals operating profit after the actual effective tax rate divided by average equity plus carrying funded debt less cash and financial investments. Goodwill and pension assets remain included; operating leases are excluded. On that convention, 2021–2025 returns are approximately 14.9%, 18.2%, 23.2%, 23.6% and 16.4%. The trailing September result is approximately 17.3%. These are accounting-return reconstructions, not project IRRs. [S1] [S2] [S10] [S11] [S12] [S39]

For 2025, $543.7 million of operating profit produces approximately $406.2 million of NOPAT at the actual 25.3% tax rate. Average capital is $2.470 billion. The decline from 2024 reflects both lower petroleum profit and a larger acquisition-inclusive denominator. Actual-tax changes also influence the annual series; they should not be interpreted entirely as changes in operating efficiency.

Matched research capitalization tests an omitted asset. With a three-year straight-line life and amortization beginning after spending, average additional research capital is $262.5 million and 2025 research amortization $134.4 million. Replacing current $132.1 million expense with that amortization produces approximately 14.8% ROIC. A five-year life adds $402.4 million of average capital and produces approximately 14.0%. Both numerator and denominator change. [S1] [S11] [S12]

The adjustment is a sensitivity, not a measured research life. Obsolescence, taxes and overlap with acquired technology remain uncertain. Retaining pension assets while excluding nonservice pension income also depresses the narrowly defined operating return. Removing the gross pension asset without matching obligations and tax effects would introduce another mismatch. The defensible conclusion is that returns remain attractive but their exact magnitude is definition-sensitive.

Liquidity, obligations and accounting quality

September funded debt was $830.1 million and cash $77.3 million. Revolver availability was approximately $614 million. Bank-defined leverage was 1.14 times against a normal 3.75-times ceiling. Debt includes $400 million face value of 2.70% notes due in 2031 and three remaining $50 million annual payments on the 3.78% notes through 2029. Most cash was held abroad, although management does not anticipate significant tax consequences from future distributions. [S2]

Material economic obligations extend beyond funded debt. Recognized operating lease liabilities total approximately $84.9 million. Environmental remediation, hazardous-material handling, product-performance obligations, unfunded benefit arrangements and potentially severe site events also matter. September environmental accruals were approximately $11 million; recognized reserves are not a ceiling on an extreme loss. [S1] [S2]

Accounting is conventional and audited, with effective annual controls reported. Material judgment is concentrated in pensions, acquired intangible valuations, useful lives and purchase accounting. Small historical rebate true-ups are reassuring, but do not eliminate acquisition-estimate risk. Cash capex must also be distinguished from additions to long-lived assets, which include lease-related assets. Company Financials fields that combine these scopes are not substituted for filed cash expenditures.

Verdict: Through-cycle profitability and cash generation remain strong, and ordinary financing risk is low. The latest earnings increase is less compelling after tax, research timing and pension income are separated. Cash conversion and acquisition-inclusive returns are now the most consequential financial tests.

Capital Allocation

Cash generation and actual deployment

NewMarket’s historical record is strongest in share retirement, dividends and debt management. The specialty acquisitions have generated earnings progress, but their ultimate returns remain less well established. During FY2021–2025, approximately $1.62 billion of calculated FCF supported $457 million of dividends and $556 million of cash repurchases, alongside acquisitions and changes in debt. The relevant allocation philosophy is flexible long-term deployment, rather than a fixed distribution formula. [S1] [S10] [S11] [S12]

Individual annual uses need not equal FCF because the company can borrow, use financial assets and adjust cash. The 2021–2022 repurchases occurred during weak cash conversion, followed by substantial cash generation and balance-sheet repair. That history supports allocation flexibility, while also illustrating why liquidity and the price paid must be considered together.

Outstanding shares declined from approximately 10.36 million at year-end 2021 to 9.20 million in September 2026. During the first nine months of 2026, the company repurchased 204,927 shares for approximately $126.4 million of cash, roughly $617 per share. Net shares declined by 200,454 after awards and withholding. The cash-flow amount differs from the equity-statement charge because those statements include different timing and associated items; the cash figure is used for deployment analysis. [S1] [S2]

Stock awards create an economic cost, but observed issuance is small relative to net share retirement. Nine-month stock-based compensation was approximately $3.0 million in the equity statement. This supports the conclusion that repurchases are doing more than offsetting large employee issuance. Grants, tax withholding and dividend-participating restricted shares still require attention when comparing per-share earnings and ending shares. [S2] [S5]

Repurchase cash was unchanged between the first-half and nine-month disclosures, indicating that substantial purchases did not continue through the summer rally. That is consistent with price discipline, but does not prove an explicit valuation process. Historical purchases that look favorable at today’s price also do not establish that all future repurchases will create value. [S2] [S4]

The board increased the quarterly dividend to $3.25 on October 29, with the next payment scheduled for January 1, 2027. The $13 annualized rate requires approximately $120 million at current shares and is covered about 3.2 times by trailing FCF. Future declarations remain discretionary. Coverage should be assessed after reinvestment and alongside repurchases, rather than treated as an isolated entitlement. S6

Acquisition scorecard

AMPAC was acquired in January 2024 for approximately $697 million. Its audited fiscal 2023 revenue was $124.0 million and operating profit $42.4 million. Adding $18.2 million of D&A gives approximately $60.6 million of historical EBITDA, implying about 11.5 times that measure. This is a pre-deal historical multiple, not a normalized forecast. Two customers represented 68% of sales and 81% of receivables. [S1] [S14]

The acquisition purchased scarce qualification, process knowledge and a specialized site. It also committed capital to a concentrated customer and program base. Historical AMPAC interest expense of $39.1 million reflected its former financing structure and should not be confused with poor manufacturing economics. Conversely, replacing the financing does not erase the acquisition price or working-capital requirements.

Calca was acquired in October 2025 for approximately $218 million. The final allocation includes $72 million of goodwill and $143 million of identified intangibles, including $102 million of customer relationships and $18 million of backlog. The company does not disclose enough stand-alone revenue, EBITDA, maintenance capex and working capital to calculate its entry multiple or post-close return reliably. Goodwill is not tax deductible. [S2]

The combined specialty platform’s $106 million trailing EBITDA shows that acquired earnings are substantial. However, segment aggregation obscures AMPAC and Calca separately. Purchase consideration, the AMPAC expansion and additional hydrazine spending all belong in the return denominator. Acquired amortization can understate current cash earnings while still representing a real resource purchased to obtain future business.

The right M&A conclusion is therefore unresolved value creation, not demonstrated failure. Increasing profit and low leverage are favorable. Missing acquisition-level cash returns and utilization data prevent a definitive success rating. A further acquisition would deserve particular scrutiny if announced before the current platform demonstrates its full-capital return.

Incentives, ownership and oversight

CEO Thomas Gottwald’s 2025 summary compensation was approximately $3.695 million, including a $1.207 million pension-value change. His annual incentive was $750,000. The annual formula establishes a maximum based on adjusted operating profit, with negative committee discretion. Long-term performance stock uses EPS at the end of a five-year period, with threshold and capped vesting. Principal disclosed formulas do not directly require ROIC or cumulative FCF. [S5]

The long horizon and restrained actual bonus support alignment. The gap matters during an acquisition cycle: debt-funded acquisitions and repurchases can increase EPS even when incremental returns disappoint. This is an incentive risk, not evidence of intent to make poor investments. The company’s stated shareholder objective—10% annual compounding over ten years, defined through EPS growth plus dividend yield—is an operating aspiration, not a guarantee of market returns or multiple stability. [S2] [S5]

Ownership provides a counterweight. The proxy’s non-overlapping buckets for Bruce Gottwald, his adult sons and separate family trusts total approximately 22.7%. CEO Thomas Gottwald’s separately reported 6.0% is already included in the sons’ bucket and must not be added again. These are dated proxy ownership disclosures, not a claim about every current family holding or identical voting arrangements. [S5]

Five of seven directors are independent; the CEO is also chair and Mark Gambill is lead director. Independent directors receive a $100,000 annual cash retainer and, under the revised arrangement, a $125,000 annual stock retainer, plus applicable committee compensation. Executive directors receive no additional board compensation. Share-ownership requirements create financial exposure, while effective challenge remains essential during the specialty expansion. [S5]

Six executive relatives received approximately $2.648 million of combined 2025 compensation. The proxy also discloses a family member’s purchase of company residential property at a stated fair value of approximately $1.2 million. Independent committee review is required for reportable related-person transactions, but the company says it has not adopted formal review procedures or approval standards. These disclosures justify scrutiny of oversight and succession without establishing misconduct. [S5]

Verified insider activity is modestly informative. Ting Xu purchased 400 shares at $619.21 in February 2026, approximately $248,000. Hazelgrove’s May 2025 sale of 311 shares carried a Rule 10b5-1 indicator. Bruce Gottwald’s September 2026 transfer of 132 shares was a gift. These are economically different transactions. The historical insider enumeration is incomplete, so no exhaustive claim of absent buying or selling is made. [S31] [S32] [S33]

Verdict: Repurchases, dividends and balance-sheet repair support an owner-oriented historical record. Specialty M&A remains the principal unresolved allocation test. Ownership alignment is substantial, while EPS incentives, related-party arrangements and limited return disclosure increase the value of independent capital-return scrutiny.

Changes and Headwinds — Last Two Years

The largest change is strategic: NewMarket has become the owner of a defense and space chemical platform alongside its mature petroleum franchise. AMPAC and Calca added approximately $915 million of purchase consideration before follow-on expansion. Their operating cultures share difficult chemistry, safety and qualification requirements with Afton, but their program timing, customer concentration and investment needs differ. Strategic adjacency is plausible; attractive financial adjacency must still be demonstrated. [S1] [S2]

External inputs, logistics, currencies and demand interact with internal pricing, research, production and capital decisions. The latest period illustrates that interaction. Middle East disruption raised input and transit costs. Surcharges protected contribution, while inventory absorbed cash. Softer petroleum demand was external in management’s account; account selection, production scheduling and safety-stock decisions were internal responses whose effectiveness must be judged subsequently. [S2] [S3]

The volume explanation changed in emphasis. Earlier management commentary stressed reductions of low-margin business. The Q3 filing specifically identifies broad market softness, particularly lubricant additives, and retains pruning as an additional first-half influence on the nine-month comparison. A perpetual pruning explanation would exceed the disclosure and make the thesis unfalsifiable. Competitor volume growth further increases the need for application-level evidence. [S2] [S23] [S47]

Production and shipments also diverged. Management reports higher Q3 production as one contributor to inventory growth while customer shipments declined. That can reflect transit delays, inventory positioning and timing. It does not automatically establish excess or obsolete stock. It does require a later bridge from production into accepted shipments and cash. A persistent divergence would weaken the benign timing explanation and could create utilization or reserve pressure.

The capacity projects have moved closer to their expected completion. Latest capex guidance is $100–$120 million, and both specialty projects remain scheduled for year-end 2026. These are management expectations, not completed milestones. Lower guidance can reflect efficiency or payment timing; it does not independently prove lower total economic capital or stronger project returns. Commercial acceptance and utilization remain the important subsequent steps. [S2] [S3]

Calca accounting is now final. During the measurement period, identifiable intangibles decreased approximately $32 million and goodwill increased approximately $28 million. The net-income effect was immaterial. This supersedes the baseline’s provisional allocation and changes the composition of future amortizing and nonamortizing assets. It does not change purchase cash or validate the customer forecasts used in the valuation. [S2]

No significant change in critical accounting policies and estimates was reported in Q3. Acquisition measurement, pension assumptions and expanded segment disclosures nevertheless affect comparison. The important distinction is between a policy change, a measurement-period acquisition adjustment and a change in operating economics. These should not be combined into an unsupported allegation of aggressive accounting. [S1] [S2]

Leadership changed through an announced succession. Timothy Fitzgerald became CFO in January 2025. Ann Pietrantoni subsequently resigned as controller and principal accounting officer, with a November 2025 departure; the filing states that it did not arise from a dispute or disagreement. Susan Ridlehoover became principal accounting officer in February 2026 after joining as controller. These are verified transitions, rather than evidence of an accounting rupture. [S42] [S43] [S44]

Board composition also changed. Bruce Gottwald retired in December 2025, and Hazelgrove joined in February 2026 as a non-independent executive director. The resulting board retains five independent members. Continuity can preserve operating discipline, but the new portfolio also raises the importance of independent expertise in concentrated hazardous-material operations, program demand and acquisition returns. [S5] [S45] [S46]

Standards and demand continue evolving. API’s September amendment supersedes the earlier edition used in the baseline. Emergency licensing shows how technical requirements adapt during disruption. The IEA’s latest forecast increases the expected electric share of new-car sales, while specialty remains exposed to defense appropriations and spacecraft architecture. None of these developments supplies a direct, quantified NEU revenue forecast. [S15] [S21] [S41]

The financial review reopened five annual reports, the fifteen 2022–2026 quarterly reports and five annual proxies, with deeper inspection of recent periods, acquisitions and debt. Older quarterlies received targeted operating review. Complete material-current-report and historical insider enumeration was not established, so negative claims about all undiscovered events or transactions are deliberately limited.

Verdict: The environment has changed through acquired diversification, capacity investment, disruption and weaker petroleum shipments. Pricing execution remains effective, but the decisive next evidence concerns qualified demand, inventory conversion and specialty returns after commissioning.

Risk Analysis

Ordinary permanent-loss risk comes primarily from weaker operating economics, poor reinvestment and multiple compression. Financial distress is not the central case. Afton can remain a valuable franchise while lower volume, normalized margins or disappointing specialty returns materially reduce equity value. The risk matrix separates those ordinary pathways from less likely but more severe operational events. [S1] [S2]

Likelihood labels are qualitative analyst assessments, not statistical probabilities. The evidence supports identifying mechanisms and severity more strongly than assigning numerical event odds. Several risks can interact: weak demand can prevent inventory release, lower utilization and delay the cash expected to reduce acquisition debt.

Petroleum margin sensitivity is material. A one-percentage-point margin change on approximately $2.5 billion of sales changes operating profit by about $25 million and after-tax profit by about $19 million at a 23% assumption. A move from 20.7% toward 17% would therefore reduce earnings substantially without a revenue collapse. A lower multiple applied to lower profit compounds the equity impact. [S2]

Shipment weakness has more than one adverse pathway. Structural demand attrition can reduce the available profit pool even if share is stable. Competitive loss can weaken technical scale and plant utilization. Elective pruning can be beneficial, but only if surrendered contribution is low and costs or capital adjust appropriately. The same shipment percentage can therefore imply different future economics. Disclosure that resolves attribution is more valuable than a generic reassurance about industry fundamentals.

Inventory introduces a cash and production risk distinct from accounting profit. If input costs and transit normalize while demand holds, working capital can release cash. If demand weakens, the company may need slower production, concessions or reserves. The filing does not establish the balance between these outcomes. A cash recovery supported mainly by stretched payables would be less persuasive than inventory conversion and collection of receivables.

Specialty concentration can magnify normal timing changes. Historical AMPAC customer concentration does not prove equivalent current combined-segment exposure, but it establishes that consolidated customer thresholds can conceal significant dependence inside a small business. A program delay need not involve customer defection to reduce quarterly profit. Capacity installed ahead of such deliveries can also depress returns through idle fixed costs and additional working capital. [S14]

A catastrophic investment loss could arise from a severe plant accident, contamination, prolonged regulatory shutdown or product failure that interrupts qualified supply and creates liabilities beyond insurance recovery. Qualification barriers can lengthen recovery if another plant cannot immediately supply an approved product. The economic moat and operational concentration are consequently connected: the difficulty of replacement supports pricing in normal conditions and increases interruption severity. [S1]

Public information does not provide a complete replacement-time, business-interruption-insurance and alternate-site-qualification bridge. Recognized environmental reserves address known obligations, not every possible future event. A severe loss should therefore be considered separately from ordinary EBITDA or covenant stress, without inventing an event probability or an unsupported insurance shortfall.

Total loss appears remote under the present financing structure. A plausible pathway would require several failures together: substantial operational or legal liabilities, severe petroleum franchise deterioration, unsuccessful leveraged expansion and an inability to refinance. Current leverage makes an ordinary earnings downturn unlikely to create that outcome. It does not protect shareholders from paying too much or funding acquisitions that fail to earn their cost of capital. [S2]

The adverse case also has limits. No disclosed customer loss proves competitive erosion, specialty profit has increased, and the balance sheet allows time for execution. Combining immediate disqualification, permanent inventory impairment, a margin collapse and refinancing failure would overstate current evidence. The more credible downside begins with observable shipment, contribution and cash-return deterioration.

Verdict: Operating and valuation risks dominate ordinary financing risk. Petroleum volume and margin must be monitored together, followed by inventory conversion and specialty utilization. Concentrated hazardous-site risk deserves separate treatment because standard leverage ratios do not capture its severity.

Valuation Discussion

Current capitalization and earnings scope

At $783.66 and 9.196910 million September shares, equity capitalization is approximately $7.207 billion. Adding $752.737 million of filed net debt produces enterprise value of approximately $7.960 billion. The primary bridge excludes operating leases. Adding the $84.9 million recognized operating lease liability would increase EV by approximately 1.1%, although a fully lease-adjusted comparison also requires a matched earnings treatment. [S2] [S7]

Normalized equity earnings are approximately $403.8 million: trailing operating profit less $35.5 million of net interest, taxed at 23%, with all other income excluded. That is approximately $43.91 per current share. It is an analyst run rate, not reported EPS. The trailing reported EPS sum is $49.30, and its denominator reflects the two-class calculation and different quarterly share weights. [S1] [S2] [S3]

The current price requires durable margins and positive cash growth; neither reported P/E nor a single EBITDA multiple settles the return. A moderate-looking P/E can coexist with substantial expectations when taxes, pension income and a high operating margin support the denominator. Conversely, excluding non-operating income does not mean the associated financial asset is worthless.

No separate pension value is added centrally. The surplus can reduce funding needs, but accessibility, obligations and tax consequences require a matched analysis. An illustrative $300 million incremental financial-asset value would add approximately $33 per share. This is a sensitivity, not a verified realizable surplus, and it should not be combined with a valuation that already capitalizes the same pension income.

Own history and relevant peers

Company Financials’ year-end EV/EBITDA observations for 2014–2025 range from approximately 8.5 to 14.6 times, with a median around 12.5. The current operating multiple is below that median. Historical figures use different debt and D&A conventions, so the comparison is directional rather than a precise percentile. The mix has also changed through specialty acquisitions. [S7]

History contains both unusually depressed and unusually strong earnings denominators. The 2024 year-end multiple near 8.5 times coincided with exceptional petroleum profitability. A lower historical multiple is therefore not automatically evidence of a lower valuation of normalized cash flow. The proper comparison asks what growth, margins and reinvestment were capitalized at each date.

The principal lubricant competitors are private companies or subsidiaries of much larger parents. Berkshire, Chevron, Shell and ExxonMobil consolidated multiples are poor substitutes for Afton’s economics. Innospec is the most useful listed operating comparison for fuel additives, while Ecolab provides a quality-and-growth boundary with a substantially different service model. Neither is a complete corporate twin. [S1] [S23] [S28]

At $99.89, Innospec’s June outstanding shares imply equity value of approximately $2.460 billion. Subtracting $250.2 million of cash and adding $7.6 million of noncontrolling interest gives approximately $2.218 billion of EV, excluding leases consistently. Trailing GAAP operating profit is $128.9 million and D&A $41.5 million, producing $170.4 million of operating EBITDA. [S24] [S26] [S27]

The denominator needs normalization. Adding $42.0 million of impairment and $0.9 million of restructuring, while removing $22.0 million of contingent-consideration gains, produces approximately $191.3 million of analyst-normalized EBITDA. This is a symmetric adjustment rather than adding back every unfavorable item. It gives approximately 11.6 times normalized EBITDA, compared with 13.0 times the GAAP-based figure. [S23] [S24] [S26]

This suggests that NEU no longer carries an obvious premium on the selected normalized measure. It does not establish equivalent quality or growth. Innospec carries more performance-chemical and oilfield exposure, has different cash conversion and capital requirements, and its latest financial period is earlier. Those differences matter more than a few tenths of a multiple.

Ecolab’s $302.98 price is approximately 37 times its $8.10–$8.20 adjusted 2026 EPS outlook. Its latest release reports 7% organic sales growth, including 2% volume. That is a different demand and service proposition from Afton’s declining shipments. The comparison explains why a quality premium can persist elsewhere; it does not establish an appropriate Ecolab multiple for NewMarket. Forward adjusted P/E is also not mechanically ranked against trailing operating EV/EBITDA. [S28] [S29]

Segment value with corporate costs retained

The following sensitivities use analyst assumptions anchored to approximately $597 million of petroleum EBITDA and $106 million of specialty EBITDA reconstructed from disclosed segment D&A. Corporate deductions include a conservative allowance for holding-company and other costs. No pension surplus is added. [S1] [S2]

The central case largely preserves petroleum’s current earnings and assigns specialty a premium for qualification and expansion potential. The downside assumes ordinary normalization, not distress. The favorable case requires both resilient petroleum economics and stronger specialty output. Corporate costs are capitalized explicitly because assigning multiples to both segments without that deduction overstates enterprise value.

These values are assumption-driven diagnostics, not independent market appraisals. One turn on $600 million of petroleum EBITDA changes EV by $600 million, approximately $65 per current share. A $25 million specialty EBITDA change at 13 times changes value by approximately $35 per share. The investment outcome is sensitive to both operating performance and the multiple assigned to its persistence.

Five-year cash and terminal-economics scenarios

A separate model starts with petroleum revenue of $2.55 billion and specialty revenue of $250 million. Margins move linearly from 20.7% and 24.8% to the terminal assumptions. Corporate and other operating costs are $28 million annually. Tax is 23%. D&A rises linearly from approximately $126.7 million to the terminal amount. All figures below are analyst assumptions or calculated outputs, not guidance. [S1] [S2]

The model deducts $120 million of capex in year one, followed by the specified annual amount. Incremental working capital equals 25% of the annual consolidated revenue change. After-tax net interest is held at $27.3 million annually. There are no acquisitions, repurchases or net share issuance, and shares remain at 9.196910 million. Cash after dividends reduces net debt or accumulates as cash, which is included once in terminal equity value.

Dividend timing is included in the IRR rather than adding all dividends to the final price and applying a simple CAGR. The base cash bridge is explicit: approximately $2.214 billion of FCF less $661 million of dividends leaves $1.554 billion for debt reduction and cash accumulation. Starting net debt of $753 million becomes approximately $801 million net cash. No dollar is simultaneously allocated to buybacks or an unspecified acquisition.

Holding net interest constant understates the benefit of deleveraging in favorable paths, but also avoids forecasting cash-investment yields. Zero net share change means the model does not rely on repurchase accretion. Actual buybacks could improve or worsen per-share value depending on price; additional acquisitions would consume the retained cash and require a separate return case.

The bear scenario is an operating-normalization case with continuing positive cash generation. Its terminal equity is cushioned by accumulated cash, explaining why it differs from the immediate static downside. It is not a catastrophe scenario. A severe combined impairment producing only $450 million of EBITDA at nine times, before further cash accumulation, would imply roughly $359 per share after present net debt. That is an illustrative stress, not a probability-weighted forecast.

The base case is also demanding in specific ways. Specialty grows 12% annually at a 27% terminal operating margin, while petroleum maintains a 20% margin. Capex must remain sufficient for those outcomes. If a second specialty expansion requires much more capital, or qualified petroleum demand declines faster, FCF and terminal value fall together. Conversely, inventory normalization could improve early cash beyond the modeled incremental requirement.

A simple reverse capitalization offers another check. At an assumed 8.5% enterprise discount rate, $400–$450 million of normalized next-year enterprise cash flow requires approximately 2.8%–3.5% perpetual growth to explain current EV. This is not a full DCF and is valid only if the cash flow already deducts reinvestment needed for growth. It highlights that an unchanged mature cash stream does not explain the entire capitalization.

Verdict: Current valuation is broadly reasonable under durable-margin and successful-specialty assumptions. It still requires growth and disciplined reinvestment. The strongest valuation support comes from reconciling operating cash economics and capital allocation, rather than selecting the most flattering EBITDA definition or peer multiple.

Variant Perception

A current formal sell-side consensus dataset was not verified. Any description of market expectations is therefore inference from capitalization, operating narratives and price response. The market appears to recognize Afton’s durability and assign value to specialty growth. The October decline is consistent with reduced tolerance for weak shipments and earnings growth driven partly by tax and accounting composition, but cannot reveal the precise forecast held by investors. [S2] [S7]

The strongest bull case distinguishes volume from economic value. Afton can reject unattractive business, recover costs and retain valuable qualified relationships even when tonnes decline. Technical complexity can support contribution per formulation while mature demand grows slowly. Specialty can then add a second qualified earnings stream, with low leverage and limited dilution allowing retained cash to accrue to shareholders.

Several observations support that case. Petroleum’s trailing margin remains above 20%, specialty trailing EBITDA exceeds $100 million, the dividend increased and financial flexibility remains substantial. These are observable developments. The extrapolation to sustainable specialty cash returns after full capital remains unproven. Recognizing present progress does not require assuming that every new capacity dollar will earn a high return. [S1] [S2] [S3] [S6]

The strongest bear case is that mature-franchise margins conceal a shrinking physical base while purchased growth earns too little on its cost. Surcharges can protect current profit, lower testing expense can improve comparisons and tax normalization can reverse EPS benefits. If qualified business erodes and new capacity remains underutilized, those temporary supports will not repair the economics. A lower multiple would then reflect weaker growth and returns rather than sentiment alone.

The bear case must also confront contrary evidence. Specialty profit has increased, no disclosed customer loss proves competitive erosion, and current leverage permits a measured ramp. Inventory has a plausible disruption explanation. A thesis requiring immediate margin collapse or financing distress exceeds the record. The stronger skepticism concerns the durability of current contribution and the capital required to create the next earnings increment.

Neither of the two latest transcripts contains public analyst Q&A. Management offers direct contact after prepared remarks. It is therefore impossible to attribute specific investor questions from those calls honestly. The substantive unresolved questions are how much lost volume is elective, whether specialty growth is organic, what commitments support capacity and what return the board underwrote. These are evidence-derived diligence questions, not invented analyst quotations. [S8] [S9]

Competitor evidence makes the volume question more consequential. Lubrizol’s first-half growth and Innospec’s Q2 fuel-volume increase contradict a universal supplier-volume contraction. Portfolio and period differences prevent a direct market-share conclusion. The appropriate variant is consequently conditional: Afton’s pricing resilience is better established than its current demand quality, and specialty earnings progress is better established than acquisition value creation. [S23] [S47]

The factor model provides a dated statistical diagnostic. At October 30, market loading was 0.608, growth −0.229 and small-size 0.117. Reported sector loadings included Industrials 0.125, Utilities −0.091 and Materials 0.012. These are return exposures, not industry classifications or explanations of plant economics. They do not alter the operating peer set identified from company evidence. [S30]

The factor model explains approximately 14.9% of return variance, with adjusted R-squared 13.9%. Residual momentum was approximately −0.010 and residual Sharpe −0.380. Residual volatility was 0.2554, but its frequency convention was not supplied, so it is not annualized. Alpha is likewise not converted into an expected annual return without estimation conventions and significance measures.

Most observed variance remains outside this specification. Large earnings-window moves are therefore compatible with a below-one market loading. Negative residual signals do not prove overselling, informed selling, crowding or future underperformance. No verified holdings or short-position dataset supports those stronger interpretations. The diagnostic is useful for risk context, not as fundamental evidence of valuation or competitive position.

Verdict: The defensible variant is a divergence between proven franchise profitability and less-proven growth quality. The thesis should change when qualified demand, utilization and capital-inclusive cash returns change, rather than when a stock-price explanation or statistical exposure becomes more persuasive.

Fact vs. Interpretation

Reported numbers, management explanations and analyst assumptions answer different questions. The following distinctions identify the claims that carry the most investment weight. A management explanation can be credible without being independently established, and an explicitly labeled estimate can be useful without deserving the confidence attached to a filed balance. [S1] [S2] [S3]

The distinction also applies to causality. A same-day earnings move establishes an association, not a complete explanation. A rival’s volume growth challenges a blanket demand narrative, but does not prove that the rival won Afton customers. A technology demonstration establishes a substitution pathway, not the adoption rate. These limits preserve useful counter-evidence without turning it into an unsupported conclusion. [S7] [S23] [S40] [S47]

Verdict: The report’s strongest facts establish resilient profitability, weaker recent cash conversion and meaningful specialty earnings. Its most consequential estimates concern normalized margins, reinvestment and terminal value; those deserve wider ranges than the reported statements.

Open Questions

The most useful missing disclosure is a bridge from qualified demand to utilization and cash return on full committed capital. A short reconciliation would answer more than additional descriptions of attractive markets. The necessary information differs by segment because petroleum’s question is retained economic participation, while specialty’s is profitable absorption of acquired and expanded capacity. [S1] [S2]

For Afton, investors need shipment changes separated among end-market contraction, deliberate account exits, customer losses and new program wins. Price and mix should distinguish ordinary pricing from disruption surcharges where practical. A stable segment margin with continued unexplained attrition would be less reassuring than stable qualified participation with comparable contribution. The filing currently combines several of these effects.

For specialty, the priority is stand-alone AMPAC and Calca sales and cash earnings, with acquisition anniversaries separated from organic growth. Maintenance and expansion capex, working capital, amortization and utilization should be connected to the acquisition consideration. Without that bridge, it is difficult to distinguish temporarily depressed accounting returns from attractive EBITDA that consumes too much capital. [S1] [S2]

Capacity diligence should specify committed volume, customer acceptance requirements, remaining qualification, minimum economic utilization and price protection if programs slip. Mechanical completion does not answer these questions. Nor should the existence of acquired backlog be treated as proof that the entire expansion is covered by firm, profitable commitments. The public disclosure does not provide that conclusion.

Petroleum transition exposure also needs better measurement. What share of contribution comes from passenger-engine oil versus commercial, marine, industrial and driveline applications? How much revenue and profit comes from hybrid and electric-vehicle fluids? Are those products incremental opportunities, defensive adaptations or replacements for more valuable conventional content? External fleet data frame the transition but cannot supply NEU’s undisclosed application mix. [S1] [S21] [S22]

Governance questions connect directly to capital allocation. What explicit return hurdle governs acquisitions and capacity? Will the board supplement terminal EPS with capital-return or cumulative-cash measures? What independent process challenges related-party arrangements and succession decisions? Large ownership improves alignment but cannot answer whether a specific investment clears its opportunity cost. [S5]

Pension value remains a separate diligence item. The relevant analysis would match surplus assets, plan obligations, taxes, funding benefits and practical access. A gross balance-sheet addition is insufficient. Similarly, a complete insider transaction record would improve interpretation of ownership behavior, but the absence of a verified complete enumeration should not become a claim that no further transactions occurred.

Verdict: The highest-value new information would resolve retained petroleum participation, specialty utilization and full-capital cash returns. More precise operating bridges would reduce valuation uncertainty more effectively than a larger but less comparable market forecast.

What Must Be True

Bull-case tests

Stable qualified petroleum demand and profitable specialty utilization must turn operating earnings into cash. The starting premises are observable: petroleum margins remain around 20%, shipments are declining, specialty trailing EBITDA has exceeded $100 million and both projects are expected to complete by year-end. The favorable thesis requires those facts to develop into durable contribution and capital returns, rather than allowing one metric to substitute indefinitely for another. [S1] [S2] [S3]

Petroleum should sustain approximately 20% margins through normalization of input disruption and research timing, with qualified volume stabilizing relative to relevant markets. Another cumulative shipment decline exceeding approximately 10% over the next year, without a credible bridge for elective exits and industry demand, would require a substantive thesis reassessment. This threshold is an analyst monitoring rule, not proof that any particular decline represents share loss. Competitor evidence makes matched comparisons essential. [S2] [S23] [S47]

Margin quality must also hold after surcharges change. A decline below 18% for a sustained annual period, especially with petroleum operating profit below approximately $450 million and weak retained programs, would materially weaken the durable-contribution premise. A temporary squeeze followed by recovery would be less decisive because historical pass-through has lagged costs. Research expenditure and customer support should be examined alongside profit, rather than mechanically normalized away. [S1] [S2] [S10] [S15]

Specialty projects should complete and progress into qualified commercial output. A delay beyond the first half of 2027 without a credible revised timetable and economic explanation would weaken the expansion case. After ramp, organic sales and cash contribution should increase. Sustainable EBITDA above $120 million would be stronger confirmation if accompanied by utilization, maintenance spending and a full-capital return bridge. The existing $106 million trailing result is evidence of progress, not the completed return test. [S1] [S2] [S3]

Cash conversion should recover as inventory and construction requirements normalize. Over a rolling two-year period after commissioning, FCF approaching at least 80%–90% of normalized equity earnings would support the cash-generation premise, subject to separately identified growth investment. Repeatedly weak conversion without a credible inventory-to-shipment and investment-to-return bridge would falsify the assumption that present profitability becomes distributable cash. These percentages are analyst thresholds, not company targets. [S2] [S4]

Bear-case tests

The adverse thesis requires persistent economic deterioration, rather than merely lower tonnage or a falling stock. It would gain support from qualified petroleum losses, margins remaining below the high teens, specialty utilization disappointments or capital-inclusive returns below a reasonable cost-of-capital range for two post-ramp years. An impairment accompanied by reduced customer or program expectations would be more significant than an isolated accounting useful-life revision. [S1] [S2]

The bear case would be weakened or falsified by stable or rising qualified petroleum participation, approximately 20% margins through another cost cycle and specialty organic growth that produces attractive incremental cash returns without higher leverage. Durable base pricing after surcharges disappear would be especially useful. Clear evidence that maintenance and development spending remain modest relative to cash earnings would also strengthen the interpretation that amortization understates economic profit. [S1] [S2] [S3] [S15]

Common governance and allocation test

Additional acquisitions should not outrun proof from existing capital. Stand-alone cash returns, utilization and an explicit investment hurdle would make the thesis more testable. Continued opacity alongside further debt-funded purchases would increase uncertainty even if EPS rose. Conversely, disclosure alone would not establish success unless operating and cash outcomes supported it. [S2] [S5]

The decisive sequence is qualified demand, price relative to cost, operating contribution, required reinvestment and cash return on committed resources. Higher EPS from taxes, pension income or fewer shares cannot independently confirm the operating bull case. A lower share price cannot independently confirm competitive erosion. The monitoring framework changes the thesis when those economic links change, grounded in the latest quarterly filing — S2, annual filing — S1, and current operating update — S3.

Public source appendix

• S1: NewMarket 2025 Form 10-K — primary_sec_filing; published 2026-02-12; Items 1, 1A, 2 and 7; audited statements pp.41–45; Notes 2–5, 8, 17, 18 and 21; segment D&A table p.56
• S2: NewMarket Q3 2026 Form 10-Q — primary_sec_filing; published 2026-10-29; Statements pp.4–8; Note 2 final Calca allocation pp.9–10; Note 4 segment D&A p.14; Notes 5 and 9–10; MD&A pp.20–25
• S3: NewMarket Q3 and nine-month 2026 results — primary_company_release; published 2026-10-28; Release text dated October 28; segment commentary; selected cash flows; non-GAAP reconciliation, rolling EBITDA $747.030m and net debt $752.737m
• S4: NewMarket Q2 2026 Form 10-Q — primary_sec_filing; published 2026-07-30; Income and cash-flow statements; segment information; MD&A shipment, surcharge, repurchase and capital-spending discussion
• S5: NewMarket 2026 definitive proxy — primary_proxy; published 2026-03-12; Board pp.6–8; director pay pp.11–12; related transactions pp.12–13; ownership pp.14–15; CD&A pp.16–25; summary compensation p.26
• S6: NewMarket dividend increase Form 8-K — primary_sec_filing; published 2026-10-29; Item 8.01: $3.25 quarterly, $13 annualized; January 1, 2027 payment; December 15 record date
• S7: Company Financials — NEU profile, statements, prices, ratios and valuation history — third_party_financial_data; publication date unavailable; Resolved primary symbol NYSE:NEU; annual 2021–2025 statements, 2020 opening capital, TTM September 2026 EV, 2014–2025 valuation observations; 1,255 unadjusted daily prices November 1, 2021–October 30, 2026; retrieved November 1, 2026
• S8: Company Financials — NewMarket Q3 2026 earnings-call transcript — third_party_transcript_of_management; published 2026-10-29; October 29 call; Fitzgerald prepared remarks on shipments, surcharges, specialty mix and completion timetable; operator conclusion without public Q&A
• S9: Company Financials — NewMarket Q2 2026 earnings-call transcript — third_party_transcript_of_management; published 2026-07-30; July 30 call; Fitzgerald prepared remarks; specialty quarterly variation and expected late-2026 capacity; no public Q&A
• S10: NewMarket 2022 Form 10-K — primary_sec_filing; published 2023-02-15; Audited comparative income, balance-sheet and cash-flow statements; MD&A cost recovery, shipments and working capital
• S11: NewMarket 2021 Form 10-K — primary_sec_filing; publication date unavailable; Audited 2019–2021 income statements and research cohorts; 2020–2021 balance sheets; marketable securities; cash flows and pension notes
• S12: NewMarket 2023 Form 10-K — primary_sec_filing; published 2024-02-15; Audited 2021–2023 comparative financial statements; research expense; inventory release; capital and debt
• S13: NewMarket 2024 Form 10-K — primary_sec_filing; publication date unavailable; Audited statements; AMPAC purchase accounting; petroleum margins; segment D&A, debt and pensions
• S14: AMPAC audited fiscal 2023 financial statements — primary_acquired_company_financials; published 2024-02-28; Statement of operations p.4; cash flows p.7; customer concentration note: two customers 68% of sales and 81% of receivables
• S15: API 1509, 24th edition, September 2026 amendment — primary_industry_standard; published 2026-09-23; Section 6.4.4, printed p.29; Annex F.2.1, printed p.109; formulation, testing, traceability and read-across
• S17: Infineum and Kangtai Southern Asia distribution collaboration — primary_competitor_release; published 2026-07-24; Distribution arrangement for components and industrial additives; Kangtai capacity and planned Malaysian expansion
• S18: Infineum and Rianlon strategic framework — primary_competitor_release; published 2026-01-21; Formulation expertise, component manufacturing, regional sourcing and cost competitiveness; paragraphs following announcement
• S19: Infineum Indian blending facility inauguration — primary_competitor_release; published 2026-03-09; Patalganga facility operated exclusively by LSR Specialty Oils; local supply and expansion capability
• S21: IEA electric-car market update — executive summary — authoritative_industry_data; publication date unavailable; First-half 2026 market data and revised full-year 29% electric-car sales forecast; powertrain definitions
• S22: IEA Global EV Outlook 2026 — trends in electric cars — authoritative_industry_data; publication date unavailable; 2025 electric-car sales 25%, global stock approximately 5%, BEV share 65%; definition includes plug-in hybrids
• S23: Innospec Q2 2026 earnings release — primary_peer_release; published 2026-08-04; Fuel Specialties volume +7%, price/mix +3%; segment operating income $36.3m on $185.7m sales; GAAP and non-GAAP schedules
• S24: Innospec 2025 annual report — primary_peer_filing; publication date unavailable; Printed pp.33, 51 and 54: operating income, impairments, restructuring, contingent consideration and D&A
• S26: Innospec Q2 2026 Form 10-Q — primary_peer_filing; publication date unavailable; Statements pp.2–5; issued shares less treasury stock; cash, noncontrolling interest, operating income, consideration gains and D&A
• S27: Company Financials — Innospec daily prices — third_party_market_data; publication date unavailable; Resolved NASDAQ:IOSP; unadjusted August 26–October 30, 2026 prices; endpoint closes $95.66 and $99.89
• S28: Ecolab Q3 2026 earnings release — primary_peer_release; published 2026-10-27; Highlights and outlook: 7% organic sales growth, 2% volume growth; adjusted annual EPS outlook $8.10–$8.20; GAAP reconciliation
• S29: Company Financials — Ecolab daily prices — third_party_market_data; publication date unavailable; Resolved NYSE:ECL; unadjusted August 26–October 30, 2026 prices; endpoint closes $290.60 and $302.98
• S30: The factor model — October 30, 2026 snapshot — internal_quantitative_diagnostic; published 2026-10-30; Supplied exposures, residual signals and diagnostics; R-squared 0.149037; frequency and significance conventions not supplied
• S31: Ting Xu February 2026 Form 4 — primary_insider_filing; published 2026-02-25; Table I: February 24 purchase, code P, 400 shares at $619.21
• S32: Bruce Hazelgrove May 2025 Form 4 — primary_insider_filing; published 2025-05-14; Table I: May 12 sale, 311 shares at $642.43; Rule 10b5-1 indicator checked
• S33: Bruce Gottwald September 2026 Form 4 — primary_insider_filing; published 2026-09-10; Table I: September 9 gift, code G, 132 shares
• S35: NewMarket Q1 2023 Form 10-Q — primary_sec_filing; published 2023-04-27; MD&A overview and price, shipment and operating-profit discussion
• S36: NewMarket Q3 2023 Form 10-Q — primary_sec_filing; published 2023-10-26; MD&A pricing recovery, shipments, profitability and working capital
• S37: NewMarket Q1 2024 Form 10-Q — primary_sec_filing; published 2024-04-25; AMPAC acquisition accounting; first-quarter segment results; MD&A
• S38: NewMarket Q1 2026 Form 10-Q — primary_sec_filing; published 2026-04-23; MD&A overview, petroleum shipment decline, repurchases and capacity plans
• S39: NewMarket Q3 2025 Form 10-Q — primary_sec_filing; publication date unavailable; September balance sheet for trailing average-capital calculation; MD&A operating comparison
• S40: NASA — Making Future Satellite Fuel Today — primary_government_technology_source; published 2025-04-15; ASCENT alternative propellant, demonstrated mission use and commercial propulsion-system development
• S41: ILMA — API emergency provisional licensing — primary_industry_association; published 2026-03-25; March 25 announcement, updated April 9; technical substitution support, traceability, 90-day permission and testing within 180 days
• S42: NewMarket CFO succession Form 8-K — primary_sec_filing; published 2024-10-03; Item 5.02: Fitzgerald succeeds Skrobacz January 1, 2025; related finance appointments
• S43: NewMarket accounting-officer departure Form 8-K — primary_sec_filing; published 2025-11-05; Item 5.02: Pietrantoni notice October 31, departure November 26; no dispute or disagreement stated
• S44: NewMarket accounting-officer appointment Form 8-K — primary_sec_filing; published 2026-02-18; Item 5.02: Susan Ridlehoover appointed principal accounting officer February 18, 2026
• S45: NewMarket Hazelgrove board appointment Form 8-K — primary_sec_filing; published 2026-02-26; Item 5.02: February 26 appointment; non-independent executive director; no additional board compensation
• S46: NewMarket Bruce Gottwald board retirement Form 8-K — primary_sec_filing; published 2025-12-09; Item 5.02: immediate December 9 retirement; no disagreement stated
• S47: Berkshire Hathaway Q2 2026 Form 10-Q — Lubrizol operating commentary — primary_competitor_parent_filing; publication date unavailable; Printed p.44, Industrial Products: Lubrizol Q2 revenue +11.1%, first-half +7.0%; higher volumes and prices; first-half pretax earnings +16.5%